U.S. President Donald Trump announced that TrumpRx.gov will now offer more than 600 generic prescription drugs, significantly expanding the administration’s effort to lower medication costs for Americans. The government-backed platform, originally launched in January with branded medicines only, will now include widely used generic drugs such as atorvastatin for cholesterol treatment and metformin for diabetes management.
Trump revealed the expansion during a White House event attended by billionaire entrepreneur Mark Cuban, whose Cost Plus Drugs online pharmacy is partnering in the initiative. According to the administration, the update increases the number of medicines available on TrumpRx by nearly seven times.
TrumpRx does not directly sell medications. Instead, the website connects consumers to pharmacy providers offering discounted prescription drug prices. The platform will integrate pricing information and savings options from Amazon Pharmacy, Cost Plus Drugs, GoodRx, and local pharmacies, helping users compare affordable medication prices in one place.
The White House stated that generic medicines will be listed separately from discounted high-cost branded drugs. However, controlled substances and medications subject to FDA risk evaluation and mitigation strategies (REMS) will not be available through the service.
The Trump administration said the expansion is part of its broader “most-favored-nation” pricing strategy, which aims to align U.S. prescription drug prices with those paid in other developed countries. Trump previously secured agreements with 17 major pharmaceutical companies, offering temporary tariff exemptions in exchange for lower drug pricing commitments.
Officials estimate the policy could generate more than $64 billion in federal and state savings over the next decade. Still, questions remain about how much consumers will personally save, especially since purchases made through TrumpRx are generally intended for uninsured buyers and may not count toward insurance deductibles.
According to the U.S. Food and Drug Administration, more than 90% of medications sold in the United States are generic drugs, making the TrumpRx expansion a major step toward broader access to affordable healthcare.


US Strikes Iran Again After Strait of Hormuz Tanker Attack Escalates Ceasefire Tensions
Open-Source AI Models Gain Ground as Enterprises Seek Lower-Cost Alternatives, Citi Says
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies
Trump Urges Gasoline Retailers to Cut Prices to $2.50 Per Gallon, Warns of Legal Action
Iran Launches Drone Attack on Bahrain After U.S. Strikes, Strait of Hormuz Tensions Escalate
Serbia President Aleksandar Vucic to Resign, Calls Early Elections After Months of Protests
Taiwan Coast Guard Officer Finds Strength in Faith as China Increases Pressure in Taiwan Strait
Despite its best efforts, Iran won’t be able to toll the Strait of Hormuz. Here’s why
Super Micro Shares Slide After Taiwan Raids Over Alleged Nvidia AI Chip Smuggling Probe
Supreme Court Backs Lisa Cook, Defends Federal Reserve Independence Against Trump Firing Attempt
Hantavirus Cruise Ship Outbreak Triggers Global Health Alert
China Expands Export Controls, Adds 20 Japanese Companies to Restricted List
Trump Signs Memorandum Backing Americans’ Right to Repair Their Own Vehicles
Javier Milei Cabinet Chief Manuel Adorni Resigns Amid Spending Scandal Investigation
Supreme Court Blocks 5th Circuit Ruling on Abortion Pill Access
Samsung, SK Hynix to Unveil Record AI and Semiconductor Investment Plans Worth Over $646 Billion 



